Infinity Pharmaceuticals SEC Filings

Infinity Pharmaceuticals Documents 2026

This page contains all official documents and SEC filings for Infinity Pharmaceuticals stock (INFIQ, ISIN: US45665G3039). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 15 documents are available. Data is updated regularly to provide investors with a complete overview of Infinity Pharmaceuticals's regulatory filings.

Infinity Pharmaceuticals Stock analysis

Infinity Pharmaceuticals Infinity Pharmaceuticals Inc. is a biopharmaceutical company based in Cambridge, Massachusetts. It was founded in 2001 and focuses on the discovery and development of novel therapies for cancer and other serious diseases.